Center for Financial Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Hold
1,349
0.05% 112
2026
Q1
$475K Hold
1,349
0.05% 113
2025
Q4
$442K Hold
1,349
0.05% 117
2025
Q3
$381K Buy
1,349
+599
+80% +$174K 0.04% 128
2025
Q2
$209K Hold
750
0.02% 162
2025
Q1
$234K Hold
750
0.03% 143
2024
Q4
$195K Hold
750
0.03% 155
2024
Q3
$242K Sell
750
-52
-6% -$17K 0.03% 139
2024
Q2
$251K Sell
802
-49
-6% -$14.4K 0.04% 132
2024
Q1
$242K Buy
851
+49
+6% +$14.3K 0.04% 134
2023
Q4
$231K Buy
802
+52
+7% +$14.2K 0.04% 129
2023
Q3
$202K Hold
750
0.04% 132
2023
Q2
$167K Hold
750
0.04% 145
2023
Q1
$181K Hold
750
0.04% 133
2022
Q4
$197K Hold
750
0.05% 129
2022
Q3
$169K Hold
750
0.05% 131
2022
Q2
$182K Hold
750
0.05% 127
2022
Q1
$181K Sell
750
-30
-4% -$6.89K 0.04% 137
2021
Q4
$175K Hold
780
0.04% 138
2021
Q3
$166K Sell
780
-778
-50% -$179K 0.04% 137
2021
Q2
$380K Sell
1,558
-44
-3% -$10.8K 0.09% 91
2021
Q1
$399K Buy
1,602
+131
+9% +$31.3K 0.1% 86
2020
Q4
$338K Buy
1,471
+80
+6% +$18.4K 0.1% 88
2020
Q3
$354K Buy
1,391
+24
+2% +$5.95K 0.11% 80
2020
Q2
$322K Buy
1,367
+574
+72% +$131K 0.11% 78
2020
Q1
$161K Buy
793
+43
+6% +$9.39K 0.05% 115
2019
Q4
$181K Buy
+750
New +$165K 0.05% 107

Other funds holding AMGN

Center for Financial Planning's AMGN Position: Q2 2026 in Review

Center for Financial Planning held its Amgen (AMGN) position steady in Q2 2026 at 1,349 shares worth $489K. The position accounts for 0.05% of the portfolio, ranked #112.

Center for Financial Planning first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Center for Financial Planning held 1,349 shares of Amgen worth $489K as of Q2 2026.
  • Center for Financial Planning left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of Center for Financial Planning's portfolio in Q2 2026, its #112 holding.
  • Center for Financial Planning first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.